SIGMA P5/ OMEGA P7/ LAMBDA P9 Portable Ultrasound Diagnostic Scanner

K160343 · Beijing East Whale Imaging Technology Co., Ltd. · IYN · Apr 7, 2016 · Radiology

Device Facts

• Record ID: K160343
• Device Name: SIGMA P5/ OMEGA P7/ LAMBDA P9 Portable Ultrasound Diagnostic Scanner
• Applicant: Beijing East Whale Imaging Technology Co., Ltd.
• Product Code: IYN · Radiology
• Decision Date: Apr 7, 2016
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 892.1550
• Device Class: Class 2
• Attributes: Pediatric

Intended Use

The Portable Ultrasound Diagnostic Scanner is intended for use by, or under the direction of, a qualified physician for ultrasound imaging and analysis in Abdomen; Small Parts; Obstetrics; Gynecology; Cardiology; Peripheral Vessels; Urology; Pediatrics; Neonate; Trans-cranial; Musculoskeletal; Fetal; Intra-operative; Transvaginal.

Device Story

Portable ultrasound diagnostic scanner consisting of console, cart, AC adaptor, transducers, and printers. Takes acoustic signals as input via various transducers (phased, convex, linear arrays); transforms signals into digital images and flow analysis; displays output on integrated LCD. Used in clinical settings by physicians for diagnostic imaging. Supports multiple modes: B-mode, M-mode, PWD, CWD, Color Doppler, Power Doppler, and Tissue Harmonic Imaging. Facilitates clinical decision-making through real-time visualization of anatomy and blood flow. Benefits patients by providing non-invasive diagnostic information across diverse clinical applications.

Clinical Evidence

Bench testing only. Compliance with AAMI/ANSI ES60601-1, IEC 60601-1-2, IEC 60601-2-37, NEMA UD 2, ISO 10993-5, and ISO 10993-10 standards demonstrated safety and performance equivalence.

Technological Characteristics

Portable console with integrated keyboard/LCD. Transducers: 1P4V, 2P4V, 3P8V (phased array), 2C5V (convex), 12L5V (linear). Modes: B, M, PWD, CWD, Color/Power Doppler, Tissue Harmonic Imaging, TDI. Power: 110-240 VAC. Connectivity: DICOM. Software: Moderate level of concern. Biocompatibility per ISO 10993.

Indications for Use

Indicated for ultrasound imaging and analysis in abdomen, small parts, obstetrics, gynecology, cardiology, peripheral vessels, urology, pediatrics, neonate, trans-cranial, musculoskeletal, fetal, intra-operative, and transvaginal applications. Intended for use by or under the direction of a qualified physician.

Regulatory Classification

Identification

An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.

Predicate Devices

• Vivid i and Vivid q Diagnostic Ultrasound System (K102388)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and features the department's name around the perimeter. In the center is a stylized symbol that resembles a caduceus, a traditional symbol of medicine, but with three figures instead of one.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

Beijing East Whale Imaging Technology Co., Ltd. % Ms. June Li RA Manager B2-2 New City Industrial Park, No.9 KeChuang 2nd St. YiZhuang, Beijing 100023 CHINA

April 7, 2016

Re: K160343

Trade/Device Name: SIGMA P5/ OMEGA P7/ LAMBDA P9 Portable Ultrasound Diagnostic Scanner Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: II Product Code: IYN, IYO, ITX Dated: February 3, 2016 Received: February 8, 2016

Dear Ms. Li:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set

{1}------------------------------------------------

forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Robert Ools

Robert Ochs, Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration

### Indications for Use

510(k) Number (if known) K160343

#### Device Name

SIGMA P5/ OMEGA P7/ LAMBDA P9 Portable Ultrasound Diagnostic Scanner

Indications for Use (Describe)

The Portable Ultrasound Diagnostic Scanner is intended for use by, or under the direction of, a qualified physician for ultrasound imaging and analysis in Abdomen; Small Parts; Obstetrics; Gynecology; Cardiology; Peripheral Vessels; Urology; Pediatrics; Neonate; Trans-cranial; Musculoskeletal; Fetal; Intra-operative; Transvaginal.

| <div> <span> <span style="font-size: 10pt;"> <span style="font-family: Arial;"> <span style="font-weight: bold;"> <span style="text-decoration: overline;">☑</span> Prescription Use (Part 21 CFR 801 Subpart D) </span> </span> </span> </span> </div> | <div> <span> <span style="font-size: 10pt;"> <span style="font-family: Arial;"> <span style="font-weight: bold;"> <span>☐ Over-The-Counter Use (21 CFR 801 Subpart C)</span> </span> </span> </span> </span> </div> |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

***DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.***

The burden time for this collection of information is estimated to average 79 hours per response, including the
time to review instructions, search existing data sources, gather and maintain the data needed and complete
and review the collection of information. Send comments regarding this burden estimate or any other aspect
of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services

Food and Drug Administration

Office of Chief Information Officer

Paperwork Reduction Act (PRA) Staff

*[e-mail]*

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

Type of Use (Select one or both, as applicable)

Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.

{3}------------------------------------------------

System: LAMBDA P9 Portable Ultrasound Diagnostic Scanner with 1P4V probe Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

| Clinical Application | Mode of Operation | | | | | | | | |
|------------------------------------|-------------------|---|-----|-----|------------------|---------------------------------|--------------------|-------------------|--|
| Anatomy/Region of<br>Interest | B | M | PWD | CWD | Color<br>Doppler | Power<br>(Amplitude)<br>Doppler | Other*<br>Combined | Other*<br>Specify | |
| Ophthalmic | | | | | | | | | |
| Fetal | N | N | N | N | N | N | Note 1 | Notes 2,3 | |
| Abdominal | N | N | N | N | N | N | Note 1 | Notes 2,3 | |
| Intra-operative Specify | | | | | | | | | |
| Intra-operative Neuro | | | | | | | | | |
| Laparoscopic | | | | | | | | | |
| Pediatric | N | N | N | N | N | N | Note 1 | Notes 2,3 | |
| Small Organ (specify) | | | | | | | | | |
| Neonatal Cephalic | | | | | | | | | |
| Adult Cephalic | N | N | N | N | N | N | Note 1 | Notes 2,3 | |
| Trans-rectal | | | | | | | | | |
| Trans-vaginal | | | | | | | | | |
| Trans-urethral | | | | | | | | | |
| Trans-esoph.(non-Card) | | | | | | | | | |
| Musculo-skeletal<br>(Conventional) | | | | | | | | | |
| Musculo-skeletal<br>(Superficial) | | | | | | | | | |
| Intravascular | | | | | | | | | |
| Other (Ob/GYN) | N | N | N | N | N | N | Note 1 | Notes 2,3 | |
| Cardiac Adult | N | N | N | N | N | N | Note 1 | Notes 2,3 | |
| Cardiac Pediatric | N | N | N | N | N | N | Note 1 | Notes 2,3 | |
| Intravascular(Cardiac) | N | N | N | N | N | N | Note 1 | Notes 2,3 | |
| Trans-esoph. (Cardiac) | | | | | | | | | |
| Intra-cardiac | | | | | | | | | |
| Other (specify) | | | | | | | | | |
| Peripheral vessel | | | | | | | | | |
| Other (specify) | | | | | | | | | |

P = previously cleared by FDA; E = added under this appendix N = new indication; Note 1: Other Combined includes: B/M; B/PWD; B/THI; B/Color Doppler; B/Color Doppler/PWD; B/Power Doppler/PWD

Note 2: Tissue Harmonic Imaging. The feature does not use contrast agents

Note 3: TDI

Note 4: Small Organ: breast, thyroid, testes

(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health

510(k)

{4}------------------------------------------------

System: SIGMA P5/ OMEGA P7/ LAMBDA P9 Portable Ultrasound Diagnostic Scanner with 2P4V probe

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

| Clinical Application<br>Anatomy/Region of<br>Interest | Mode of Operation | | | | | | | |
|-------------------------------------------------------|-------------------|---|-----|-----|------------------|---------------------------------|--------------------|-------------------|
| | B | M | PWD | CWD | Color<br>Doppler | Power<br>(Amplitude)<br>Doppler | Other*<br>Combined | Other*<br>Specify |
| Ophthalmic | | | | | | | | |
| Fetal | N | N | N | N | N | N | Note 1 | Notes 2,3 |
| Abdominal | N | N | N | N | N | N | Note 1 | Notes 2,3 |
| Intra-operative Specify | | | | | | | | |
| Intra-operative Neuro | | | | | | | | |
| Laparoscopic | | | | | | | | |
| Pediatric | N | N | N | N | N | N | Note 1 | Notes 2,3 |
| Small Organ (specify) | | | | | | | | |
| Neonatal Cephalic | | | | | | | | |
| Adult Cephalic | N | N | N | N | N | N | Note 1 | Notes 2,3 |
| Trans-rectal | | | | | | | | |
| Trans-vaginal | | | | | | | | |
| Trans-urethral | | | | | | | | |
| Trans-esoph.(non-Card) | | | | | | | | |
| Musculo-skeletal<br>(Conventional) | | | | | | | | |
| Musculo-skeletal<br>(Superficial) | | | | | | | | |
| Intravascular | | | | | | | | |
| Other (Ob/GYN) | N | N | N | N | N | N | Note 1 | Notes 2,3 |
| Cardiac Adult | N | N | N | N | N | N | Note 1 | Notes 2,3 |
| Cardiac Pediatric | N | N | N | N | N | N | Note 1 | Notes 2,3 |
| Intravascular(Cardiac) | N | N | N | N | N | N | Note 1 | Notes 2,3 |
| Trans-esoph. (Cardiac) | | | | | | | | |
| Intra-cardiac | | | | | | | | |
| Other (specify) | | | | | | | | |
| Peripheral vessel | | | | | | | | |
| Other (specify) | | | | | | | | |

N = new indication; P = previously cleared by FDA; E = added under this appendix Note 1: Other Combined includes: B/M; B/PWD; B/THI;B/Color Doppler; B/Color Doppler/PWD; B/Power Doppler/PWD

Note 2: Tissue Harmonic Imaging. The feature does not use contrast agents Note 3: TDI

Note 3: TDI
Note 4: Q = "

Note 4: Small Organ: breast, thyroid, testes

(Division Sian Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health 510(k)

{5}------------------------------------------------

System: OMEGA P7/ LAMBDA P9 Portable Ultrasound Diagnostic Scanner with 3P8V probe

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

| Clinical Application<br>Anatomy/Region of<br>Interest | B | M | PWD | CWD | Color<br>Doppler | Power<br>(Amplitude)<br>Doppler | Other*<br>Combined | Other*<br>Specify |
|-------------------------------------------------------|---|---|-----|-----|------------------|---------------------------------|--------------------|-------------------|
| Ophthalmic | N | N | N | N | N | N | Note 1 | Notes 2,3 |
| Fetal | N | N | N | N | N | N | Note 1 | Notes 2,3 |
| Abdominal | N | N | N | N | N | N | Note 1 | Notes 2,3 |
| Intra-operative Specify | | | | | | | | |
| Intra-operative Neuro | | | | | | | | |
| Laparoscopic | | | | | | | | |
| Pediatric | N | N | N | N | N | N | Note 1 | Notes 2,3 |
| Small Organ (specify) | N | N | N | N | N | N | Note 1 | Notes 2,3,4 |
| Neonatal Cephalic | | | | | | | | |
| Adult Cephalic | | | | | | | | |
| Trans-rectal | | | | | | | | |
| Trans-vaginal | | | | | | | | |
| Trans-urethral | | | | | | | | |
| Trans-esoph.(non-Card) | | | | | | | | |
| Musculo-skeletal<br>(Conventional) | N | N | N | N | N | N | Note 1 | Notes 2,3 |
| Musculo-skeletal<br>(Superficial) | N | N | N | N | N | N | Note 1 | Notes 2,3 |
| Intravascular | N | N | N | N | N | N | Note 1 | Notes 2,3 |
| Other (Ob/GYN) | | | | | | | | |
| Cardiac Adult | | | | | | | | |
| Cardiac Pediatric | N | N | N | N | N | N | Note 1 | Notes 2,3 |
| Intravascular(Cardiac) | N | N | N | N | N | N | Note 1 | Notes 2,3 |
| Trans-esoph. (Cardiac) | | | | | | | | |
| Intra-cardiac | N | N | N | N | N | N | Note 1 | Notes 2,3 |
| Other (specify) | | | | | | | | |
| Peripheral vessel | N | N | N | N | N | N | Note 1 | Notes 2,3 |
| Other (specify) | | | | | | | | |

P = previously cleared by FDA; N = new indication; E = added under this appendix

Note 1: Other Combined includes: B/M; B/PWD; B/THI;B/Color Doppler; B/Color Doppler/PWD; B/Power Doppler/PWD

Note 2: Tissue Harmonic Imaging. The feature does not use contrast agents Note 3: TDI

Note 4: Small Organ: breast, thyroid, testes

(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health 510(k)

{6}------------------------------------------------

System: SIGMA P5/ OMEGA P7/ LAMBDA P9 Portable Ultrasound Diagnostic Scanner with 2C5V probe

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

| Clinical Application<br>Anatomy/Region of<br>Interest | Mode of Operation | | | | | | | | |
|-------------------------------------------------------|-------------------|---|-----|-----|------------------|---------------------------------|--------------------|-------------------|--|
| | B | M | PWD | CWD | Color<br>Doppler | Power<br>(Amplitude)<br>Doppler | Other*<br>Combined | Other*<br>Specify | |
| Ophthalmic | | | | | | | | | |
| Fetal | N | N | N | | N | N | Note 1 | Notes 2 | |
| Abdominal | N | N | N | | N | N | Note 1 | Notes 2 | |
| Intra-operative Specify | | | | | | | | | |
| Intra-operative Neuro | | | | | | | | | |
| Laparoscopic | | | | | | | | | |
| Pediatric | N | N | N | | N | N | Note 1 | Notes 2 | |
| Small Organ (specify) | N | N | N | | N | N | Note 1 | Notes 2,4 | |
| Neonatal Cephalic | | | | | | | | | |
| Adult Cephalic | | | | | | | | | |
| Trans-rectal | | | | | | | | | |
| Trans-vaginal | | | | | | | | | |
| Trans-urethral | N | N | N | | N | N | Note 1 | Notes 2 | |
| Trans-esoph.(non-Card) | | | | | | | | | |
| Musculo-skeletal<br>(Conventional) | N | N | N | | N | N | Note 1 | Notes 2 | |
| Musculo-skeletal<br>(Superficial) | N | N | N | | N | N | Note 1 | Notes 2 | |
| Intravascular | N | N | N | | N | N | Note 1 | Notes 2 | |
| Other (Ob/GYN) | N | N | N | | N | N | Note 1 | Notes 2 | |
| Cardiac Adult | | | | | | | | | |
| Cardiac Pediatric | N | N | N | | N | N | Note 1 | Notes 2 | |
| Intravascular(Cardiac) | | | | | | | | | |
| Trans-esoph.(Cardiac) | | | | | | | | | |
| Intra-cardiac | | | | | | | | | |
| Other (specify) | | | | | | | | | |
| Peripheral vessel | N | N | N | | N | N | Note 1 | Notes 2 | |
| Other (specify) | | | | | | | | | |

N = new indication; P = previously cleared by FDA; E = added under this appendix Note 1: Other Combined includes: B/M; B/PWD; B/THI;B/Color Doppler; B/Color Doppler/PWD; B/Power Doppler/PWD

Note 2: Tissue Harmonic Imaging. The feature does not use contrast agents Note 3: TDI

Note 3: TDI
Note 4: ""

Note 4: Small Organ: breast, thyroid, testes

(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health

510(k)

{7}------------------------------------------------

System: SIGMA P5/ OMEGA P7/ LAMBDA P9 Portable Ultrasound Diagnostic Scanner with 4EC9V probe

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

| Clinical Application<br>Anatomy/Region of<br>Interest | Mode of Operation | | | | | | | |
|-------------------------------------------------------|-------------------|---|-----|-----|------------------|---------------------------------|--------------------|-------------------|
| | B | M | PWD | CWD | Color<br>Doppler | Power<br>(Amplitude)<br>Doppler | Other*<br>Combined | Other*<br>Specify |
| Ophthalmic | | | | | | | | |
| Fetal | N | N | N | N | N | N | Note 1 | Notes 2,3 |
| Abdominal | N | N | N | N | N | N | Note 1 | Notes 2 |
| Intra-operative Specify | | | | | | | | |
| Intra-operative Neuro | | | | | | | | |
| Laparoscopic | | | | | | | | |
| Pediatric | | | | | | | | |
| Small Organ (specify) | | | | | | | | |
| Neonatal Cephalic | | | | | | | | |
| Adult Cephalic | | | | | | | | |
| Trans-rectal | N | N | N | | N | N | Note 1 | Notes 2 |
| Trans-vaginal | N | N | N | | N | N | Note 1 | Notes 2 |
| Trans-urethral | N | N | N | | N | N | Note 1 | Notes 2 |
| Trans-esoph.(non-Card) | | | | | | | | |
| Musculo-skeletal<br>(Conventional) | | | | | | | | |
| Musculo-skeletal<br>(Superficial) | | | | | | | | |
| Intravascular | | | | | | | | |
| Other (Ob/GYN) | N | N | N | | N | N | Note 1 | Notes 2 |
| Cardiac Adult | | | | | | | | |
| Cardiac Pediatric | | | | | | | | |
| Intravascular(Cardiac) | | | | | | | | |
| Trans-esoph. (Cardiac) | | | | | | | | |
| Intra-cardiac | | | | | | | | |
| Other (specify) | | | | | | | | |
| Peripheral vessel | N | N | N | | N | N | Note 1 | Notes 2 |
| Other (specify) | | | | | | | | |

P = previously cleared by FDA; N = new indication; E = added under this appendix Note 1: Other Combined includes: B/M; B/PWD; B/THI;B/Color Doppler; B/Color Doppler/PWD;

B/Power Doppler/PWD

Note 2: Tissue Harmonic Imaging. The feature does not use contrast agents

Note 3: TDI

Note 4: Small Organ: breast, thyroid, testes

(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health

{8}------------------------------------------------

System: SIGMA P5/ OMEGA P7/ LAMBDA P9 Portable Ultrasound Diagnostic Scanner with 12L5V probe

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

| Clinical Application<br>Anatomy/Region of<br>Interest | Mode of Operation | | | | | | | |
|-------------------------------------------------------|-------------------|---|-----|-----|------------------|---------------------------------|--------------------|-------------------|
| | B | M | PWD | CWD | Color<br>Doppler | Power<br>(Amplitude)<br>Doppler | Other*<br>Combined | Other*<br>Specify |
| Ophthalmic | N | N | N | | N | N | Note 1 | Notes 2 |
| Fetal | | | | | | | | |
| Abdominal | N | N | N | | N | N | Note 1 | Notes 2 |
| Intra-operative Specify | | | | | | | | |
| Intra-operative Neuro | | | | | | | | |
| Laparoscopic | | | | | | | | |
| Pediatric | N | N | N | N | N | N | Note 1 | Notes 1 |
| Small Organ (specify) | N | N | N | N | N | N | Note 1 | Notes 2,4 |
| Neonatal Cephalic | | | | | | | | |
| Adult Cephalic | | | | | | | | |
| Trans-rectal | | | | | | | | |
| Trans-vaginal | | | | | | | | |
| Trans-urethral | | | | | | | | |
| Trans-esoph.(non-Card) | | | | | | | | |
| Musculo-skeletal<br>(Conventional) | N | N | N | | N | N | Note 1 | Notes 2 |
| Musculo-skeletal<br>(Superficial) | N | N | N | | N | N | Note 1 | Notes 2 |
| Intravascular | | | | | | | | |
| Other (Ob/GYN) | | | | | | | | |
| Cardiac Adult | | | | | | | | |
| Cardiac Pediatric | | | | | | | | |
| Intravascular(Cardiac) | | | | | | | | |
| Trans-esoph. (Cardiac) | | | | | | | | |
| Intra-cardiac | | | | | | | | |
| Other (specify) | | | | | | | | |
| Peripheral vessel | N | N | N | | N | N | Note 1 | Notes 2 |
| Other (specify) | | | | | | | | |

N = new indication; P = previously cleared by FDA; E = added under this appendix Note 1: Other Combined includes: B/M; B/PWD; B/THI;B/Color Doppler; B/Color Doppler/PWD; B/Power Doppler/PWD

Note 2: Tissue Harmonic Imaging. The feature does not use contrast agents

Note 3: TDI

Note 4: Small Organ: breast, thyroid, testes

(Division Sian Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health 510(k)

{9}------------------------------------------------

# 510(k) Summary of Safety and Effectiveness

[As required by 21 CFR 807.92]

# 1. Date Prepared [21 CFR807.92 (a) (1)]

Apr 6th 2016

# 2. Submitter's Information [21 CFR807.92 (a) (1)]

Name of Sponsor: Beijing East Whale Imaging Technology Co., Ltd.

| Address: | B2-2 New City Industrial Park, No.9 KeChuang 2nd St.,<br>YiZhuang, 100023, Beijing, China. |
|----------------|--------------------------------------------------------------------------------------------|
| Contact Name: | June Li |
| Telephone No.: | + 86 (10) 67892355-8968 |
| Fax No.: | + 86 (10) 67082218 |
| Email Address: | [e-mail] |

# 3. Trade Name, Common Name, Classification [21 CFR807.92(a)(2)]

| Common Name: | Portable Ultrasound Diagnostic Scanner |
|----------------------|-----------------------------------------------------------------------------------|
| Model: | P5/ P7/ P9 |
| Trade Name: | SIGMA P5/ OMEGA P7/ LAMBDA P9 Portable Ultrasound<br>Diagnostic Scanner |
| Classification Name: | Ultrasonic Pulsed Doppler Imaging System<br>Ultrasonic Pulsed Echo Imaging System |

{10}------------------------------------------------

### Diagnostic Ultrasound Transducer

Classification Regulation: 892.1550/ 892.1560/ 892.1560

ll

| Product code: | IYN/ IYO/ ITX |
|-----------------------|---------------|
| Classification Panel: | Radiology |

Device Class:

## 4. Identification of Predicate Device(s) [21 CFR 807.92(a)(3)]

| 510(k) Number | K102388 |
|---------------|------------------------------------------------------------------------------------|
| Applicant | GE Healthcare [GE Medical Systems Ultrasound and<br>Primary Care Diagnostics, LLC] |
| Device Name | Vivid i and Vivid q Diagnostic Ultrasound System |

### 5. Description of the Device [21 CFR 807.92(a)(4)]

The Portable Ultrasound Diagnostic Scanner comprises of a console, a cart, an AC adaptor, and several transducers and printers. The console is a portable ultrasound diagnostic device with an integrated keyboard and LCD display. It is capable of digital acquisition, processing and display. The mobile cart with multiple socket-outlet and extension transducer connector improves the mobility by having all accessories on it.

### 6. Intended Use [21 CFR 807.92(a)(5)]

The Portable Ultrasound Diagnostic Scanner is intended for use by, or under the direction of, a qualified physician for ultrasound imaging and analysis in Abdomen; Small Parts; Obstetrics; Gynecology; Cardiology; Peripheral Vessels; Urology; Pediatrics; Neonate; Trans-cranial; Musculoskeletal; Fetal; Intra-operative; Transvaginal.

## 7. Technological Characteristics [21 CFR 807.92(a)(6)]

{11}------------------------------------------------

The Portable Ultrasound Diagnostic Scanner employs the same fundamental technological characteristics as its predicate devices.

# 8. Substantial Equivalence [21 CFR 807.92(b)(1) and 807.92(b)(2)]

Results of performance and compliance testing conducted on Portable Ultrasound Diagnostic Scanner, indicates conformance to all applicable standards recognized by FDA for this device.

Based on non-clinical test results, Portable Ultrasound Diagnostic Scanner is substantially equivalent to predicate devices in safety and effectiveness.

### Non-clinical testing:

The proposed device has been tested to compliance to the following safety and performance standards:

AAMI / ANSI ES60601-1:2005/(R)2012 And A1:2012,, C1:2009/(R)2012 And A2:2010/(R)2012 IEC 60601-1-2: 2007 IEC 60601-2-37: 2007 NEMA UD 2: 2004 ISO 10993-5:2009 ISO 10993-10:2010

#### Comparison with Predicated Device:

The proposed device is substantially equivalent in safety and effectiveness to the proposed device:

| Items | Proposed Device | Predicate Device | Remark |
|-----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
| Intended<br>Use | The Portable Ultrasound<br>Diagnostic Scanner is intended for<br>use by, or under the direction of, a<br>qualified physician for ultrasound<br>imaging and analysis in Abdomen; | the Vivid ilq ultrasound systems<br>are intended for use by, or under<br>the direction of, a qualified<br>physician for ultrasound imaging<br>and analysis in Abdominal/GYN;<br>Urology; | Note 1 |

{12}------------------------------------------------

| | Small Parts; Obstetrics;<br>Gynecology; Cardiology;<br>Peripheral Vessels; Urology;<br>Pediatrics; Neonate; Trans-cranial;<br>Musculoskeletal; Fetal;<br>Intra-operative; Transvaginal. | Fetal/OB3; Small Organ (breast,<br>testes, thyroid); Pediatric;<br>Neonatal &<br>Adult Cephalic; Cardiac (adult &<br>pediatric); Peripheral Vascular;<br>Musculo-skeletal (conventional &<br>superficial); Transesophageal;<br>Intraoperative (abdominal,<br>thoracic and PV); Transvaginal<br>and<br>Transrectal, Intra-cardiac and<br>intra-lumninal applications. | | | |
|---------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------|
| Classification<br>Name | Ultrasonic Pulsed Doppler Imaging<br>System<br>Ultrasonic Pulsed Echo Imaging<br>System<br>Diagnostic Ultrasound Transducer | Ultrasonic Pulsed Doppler<br>Imaging System<br>Ultrasonic Pulsed Echo Imaging<br>System<br>Diagnostic Ultrasound Transducer | Same | | |
| Product<br>Code | IYN/ IYO/ ITX | IYN/ IYO/ ITX | Same | | |
| Regulation<br>n Number | 892.1550/892.1560/892.1570 | 892.1550/892.1560/892.1570 | Same | | |
| Panel | Radiology | Radiology | Same | | |
| Class | II | II | Same | | |
| Probe<br>Type | 1P4V, Phrase Array<br>2P4V, Phrase Array<br>3P8V, Phrase Array<br>2C5V, Convex Array<br>12L5V, Linear Array | 3Sc-RS, Phased Array<br>3S-RS, Phased Array<br>7S-RS, Phased Array<br>3C-RS, Convex Array<br>8L-RS, Linear Array | Same | | |
| | | 4EC9V, Intracavitary Convex<br>Array, 4-9MHz | | e8C-RS, Intracavitary Convex<br>Array, 4.0 - 11.0 MHz | |
| | Acoustic<br>Track | TRACK 3 | | TRACK 3 | Same |
| | Imaging<br>mode | 2D(B) mode, M-Mode,<br>AMM-Mode, Color Doppler, Power<br>Doppler (Angio), Tissue Velocity<br>Imaging (TVI) mode, PW mode,<br>CW mode, Tissue-Doppler<br>imaging (TVD) mode, TDI, and<br>some application functions | | 2D (B) Mode, Color<br>Doppler, Power Doppler (Angio),<br>M-Mode, Color M-Mode, PW and<br>CW Doppler spectra,<br>Tissue-Doppler imaging (TDI) and<br>LVO Contrast option applications | Same |
| Power<br>Supply | Voltage: 110-240 VAC<br>Frequency: 50/60 Hz | Voltage: 110-240 VAC<br>Frequency: 50/60 Hz | Same | | |
| Acoustic<br>Output | Track 3:MI,TIS,TIC,TIB<br>Derated ispta: 720Mw/cm² maximum.<br>TIS/TIB/TIC: 6.0 Maximum,<br>Mechanical Index: 1.9 Maximum,<br>or Derated Isppa: 190W/cm² max | Track 3: MI,TIS,TIC,TIB<br>Derated ispta: 720Mw/cm² maximum.<br>TIS/TIB/TIC: 6.0 Maximum,<br>Mechanical Index: 1.9 Maximum,<br>or Derated Isppa: 190W/cm² max | Same | | |
| Electrical<br>Safety | IEC 60601-1 | IEC 60601-1 | Same | | |
| EMC | IEC 60601-1-2 | IEC 60601-1-2 | Same | | |
| Performa<br>nce | IEC 60601-2-37<br>NEMA UD 2: 2004 | IEC 60601-2-37<br>NEMA UD 2: 2004 | Same | | |
| Biocomp<br>atibility | ISO 10993-5,<br>ISO 10993-10 | ISO 10993-5,<br>ISO 10993-10 | Same | | |
| Level of<br>Concern<br>Of<br>Software | Moderate level of concern system | Moderate level of concern system | Same | | |
| Design | Console+Cart+Probe+ECG+<br>Printer<br>DICOM | Console+Cart+Probe+ECG+<br>Printer<br>DICOM | Same | | |

{13}------------------------------------------------

{14}------------------------------------------------

Note 1: Intended use of proposed device is similar with predicate device. Applications of the predicate device cover all the applications of proposed device, and thus the difference will not affect safety and efficiency of device.

The proposed device has similar intended use, similar product design, similar performance effectiveness, and performance safety as the predicate device. The differences between the proposed device and predicate device do not affect the basic design principle, usage, effectiveness and safety of the proposed device. And no new risk is raised regarding to effectiveness and safety. The proposed device is substantial with the predicated device.

### 9. Conclusion [21 CFR 807.92(b) (3)]

In accordance with the Federal Food, Drug and Cosmetic Act, 21 CFR Part 807 and based on the information provided in this premarket notification, we concludes that Portable Ultrasound Diagnostic Scanner is substantially equivalent to predicate devices with regard to safety and effectiveness.